Wpływ wybranych składników żywności na aktywność psychofizyczną człowieka

• Autorzy: Leszczynska T , Pisulewski P M
• Języki publikacji: PL

Abstrakty

PL

Dokonano przeglądu potencjalnego wpływu wybranych składników żywności na aktywność umysłową oraz ryzyko wystąpienia dysforii, demencji i depresji. Przedstawiono dowody na kluczową rolę m.in. witamin z grupy B i witamin przeciwutleniających w ochronie przed niekorzystnymi zmianami w naczyniach krwionośnych, aterosklerozą i demencją. Wskazano równie na udział choliny, alkoholu i kofeiny w funkcjonowaniu centralnego układu nerwowego oraz diety na syntezę neuroaktywnego składnika – β-endorfiny.

EN

In the paper presented, the authors review the potential impact of selected nutrients on mental activity, as well as the risk of dysphoria, dementia, and depression to occur in people. Evidence was provided that the B-complex and antioxidant vitamins play an important role in the protection against unfavorable changes in blood-vessels, as well as against arteriosclerosis and dementia diseases. It was demonstrated that such substances as choline, alcohol, and caffeine are significantly involved in the functioning of the central nerve system, and that a diet influences the synthesis of ß-endorphin, which is a neuro-active substance.

Słowa kluczowe

PL

endorfiny; beta-karoten; witaminy grupy B; cholina; przeciwutleniacze; kofeina; witamina E; choroby czlowieka; depresja; witamina C; dysforia; aktywnosc psychofizyczna; otepienie; zywienie czlowieka; skladniki odzywcze

EN

endorphin; beta-carotene; B-group vitamin; choline; antioxidant; caffeine; vitamin E; human disease; depression; vitamin C; dysphoria; psychophysical activity; dementia; human nutrition; nutritional component

• Wydawca: -
• Czasopismo: Żywność Nauka Technologia Jakość
• Rocznik: 2004
• Tom: 11
• Numer: 1
• Opis fizyczny: s.12-24,rys.,bibliogr.

Twórcy

autor

Leszczynska T

• Katedra Żywienia Człowieka, Akademia Rolnicza, al. 29 listopada 46, 31-425 Kraków

autor

Pisulewski P M

• Katedra Żywienia Człowieka, Akademia Rolnicza, al. 29 listopada 46, 31-425 Kraków

Bibliografia

• [1] Adams W.R., Kiefer S.W., Badia-Elder N.: Tryptophan deficiency and alcohol consumption in rats as a model for disadvantaged human populations: a preliminary study. Med. Anthropolog., 1995, 16, 175-191.
• [2] Alpert J.E., Fava M.: Nutrition and depression: The role of folate. Nutr. Rev., 1997, 55, 145-149.
• [3] Anderson K.J., Ravelle W.: Impulsivity, caffeine and proof-reading: a test the Easterbrook hypothesis. J. Exp. Psychol.: Human Perception Performance, 1982, 8, 614-624.
• [4] Bartus R.T., Dean R.L., Beer B., Lippa A.S.: The cholinergic hypothesis of geriatric memory dysfunction. Science, 1982, 216, 408-417.
• [5] Bellisle F., Blundell J.E., Dye L., Fantino M., Fern E., Fletcher R.J., Lambert J., Roberfroid M., Specter S., Westenhofer J., Westerterp-Plantenga M.S.: Functional food science and behavior, and psychological functions. Br. J. Nutr., 1998, 80 Suppl. 1, 173-193.
• [6] Bell I.R., Edman J.S., Miller J., Hebben N., Linn R.T., Ray D., Kayne H.L.: Relationship of normal serum vitamin B12 and folate levels to cognitive test performance in subtypes of geriatric major depression. J. Geriat. Psych. Neurol., 1990, 3, 98-105.
• [7] Bell I.R., Edman J.S., Selhub J., Morrow F.D., Marby D.W., Kayne H.L., Cole J.O.: Plasma homocysteine in vascular disease and in nonvascular dementia of depressed elderly people. Acta Psychiatrica Scand., 1992, 86, 386-390.
• [8] Berr C., Richard M.J., Roussel A.M., Bonithon-Kopp C.: Systemic oxidative stress and cognitive performance in the population-based EVA study. Free Rad. Biol. Med., 1998, 24, 1202-1208.
• [9] Blass E., Fitzgerald E., Kehoe P.: Interactions between sucrose, pain and isolation distress. Pharmacol. Bioch. Behavior, 1987, 26, 483-489.
• [10] Blass E., Fitzgerald E.: Milk-induced analgesia and comforting in 10-day-old rats: opioid mediation. Pharmacology, Biochemistry and Behavior, 1988, 29, 9-13.
• [11] Chome J., Paul T., Pudel V., Bleyl J., Hesker H., Huppe R., Kubleer W.: Effects of sub-optimal vitamin status on behavior. Bibliotheca Nutritio et Dieta, 1986, 38, 94-103.
• [12] Clarke R., Daly L., Robinson K., Naughten E., Cahalane S., Fowler B., Graham I.: Hyperhomocysteinemia: An independent risk factor for vascular disease. New Eng. J. Med., 1991, 324, 1149-1155.
• [13] Deijen J.B., van der Beek E.J., Orlebeke J.F., van der Berg H.: Vitamin B-6 supplementation in elderly men: effects on mood, memory and mental effort. Psychopharmacology, 1992, 109, 489-496.
• [14] Dum J., Gramsch C., Ferz A.: Activation of hypothalamic β-endorphin pools by reward induced by highly palatable food. Pharmacol., Bioch. Behavior, 1983, 18, 443-447.
• [15] Frei B., Keaney J.F., Retsky K.L., Chen K.: Vitamins C and E and LDL oxidation. Vitamins and Hormones, 1996, 52, 1-34.
• [16] Gale C.R., Martyn C.R., Cooper C.: Cognitive impairment and mortality in a cohort of elderly people. Br. Med. J., 1996, 312, 608-611.
• [17] Gibson L.E., Green M.W., Nutritional influences on cognitive function: mechanisms of susceptibility. Nutr. Res. Rev., 2002, 15, 169-206.
• [18] Godfrey P.S.A., Toone B.K., Carney M.W.P., Flynn T.G., Bottiglieri T., Laundy M., Chanarin I., Reynolds E.H.: Enhancement of recovery from psychiatric illness by methylofolate. Lancet, 1990, 336, 392-395.
• [19] Haller J., Waggemans R.M., Ferry M., Guigoz Y.: Mental health: mini-mental state examination and geriatric depression scores for elderly Europeans in the SENECA study of 1993. Eur. J. Clin. Nutr., 1996, 50 Suppl. 2, S112-S116.
• [20] Hindmarch I., Kerr J.S., Sherwood N.: The effects of alcohol and other drugs on psychomotor performance and cognitive function. Alcohol and Alcoholism, 1991, 26, 71-79.
• [21] Jama J.W., Launer L.J., Witterman J.C.M., denBreeijen J.H., Breteler M.M.B., Grobbee D.E., Hofman A.: Dietary antioxidants and cognitive function in a population-based sample of elder persons: The Rotterdam Study. Am. J. Epidemiol., 1996, 144, 275-280.
• [22] James J.E.: Caffeine and Health. London: Academic Press 1991.
• [23] Jarvis M.J.: Does caffeine intake enhance absolute levels of cognitive performance? Psychopharmacology, 1993, 110, 45-52.
• [24] Kalmijn S., Feskens E.J.M., Launer L.J., Kromhout D.: Polyunsaturated fatty acids, antioxidants, and cognitive function in very old men. Am. J. Epidemiol., 1997, 145, 33-41.
• [25] Kalmijn S., Launer L.J.Lindemans J., Bots M.L., Hofman A., Breteler M.M.B.: Total homocysteine and cognitive decline in a community-based sample of elderly subjects: The Rotterdam Study. Am. J. Epidemiol., 1999, 150, 283-289.
• [26] Kaye W.H., Pickar D., Naber D., Ebert M.H.: Cerebrospinal fluid opioid activity in anorexia nervosa. Psychiatry, 1982, 139, 643-645.
• [27] Koehler K.M., Romero I.J., Stauber P.M., Pareotubbeh S.L., Liang H.C., Baumgartner R.N., Garry P.J., Allen R.H., Stabler S.P., Vitamin supplementation and other variables affecting serum homocysteine and methylmalonic acid concentrations in elderly men and women. J. Am. College Nutr., 1996, 15, 363-376.
• [28] La Rue A., Koehler K., Wayne S.J., Chiulli S.J., Haaland K.Y., Garry P.J. Nutritional status and cognitive functioning in a normally aging sample: a 6-y reassessment. Am. J. Clin. Nutr., 1997, 65, 20-29.
• [29] Lehmann M., Gottfries C.G., Regland B.: Identification of cognitive impairment in the elderly: Homocysteine is an early marker. Dementia and Geriatric Cognitive Disorders, 1999, 10, 12-20.
• [30] Lethem R., Orrell M.: Antioxidants and dementia. Lancet, 1997, 349, 1189-1190.
• [31] Lindenbaum J., Healton E.B., Savage D.G., Brust J.C., Garrett T.J., Podell E.R., Marcel P.D., Stabler S.P., Allen R.H.: Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. New Eng. J. Med., 1988, 318, 1720-1728.
• [32] Linder M.C.: Nutritional Biochemistry and Metabolism: With Clinical Applications, 2nd ed. Norwalk, CT: Appleton and Lange, 1991.
• [33] Lussier-Cacan S., Xhingnesse M., Piolot A., Selhub J., Davignon J., Genest J.: Plasma total homocysteine in healthy subjects: Sex specific relation with biological traits. Am. J. Clin. Nutr., 1996, 64, 587-593.
• [34] Matsumura M., Fukuda N., Saito S., Mori H.: Effect of a test meal, duodenal acidification, and tetragastrin on the plasma concentration of β-endorphin-like immune reactivity in man. Regulatory Peptides, 1982, 4, 173-181.
• [35] McCaddon A., Davies G., Hudson P., Tandy S., Cattell H.: Total serum homocysteine in senile dementia of the Alzheimer type. International J. Geriat. Psych., 1998, 13, 235-239.
• [36] McGivern R.F., Berntson G.G.: Mediation of diurnal fluctuations in pain sensitivity in the rat by food intake patterns: reversal by naloxone. Science, 1980, 210, 210-211.
• [37] Melchior J.C., Fantino M., Colas-Linhart N., Rigaut D., Petiet A., Laforest M.D., Fumeron F., Apfelbaum M.: Lack of plasmatic beta-endorphin response to a gastronomic meal in healthy humans. Physiol. and Behavior, 1991, 49, 1217-1221.
• [38] Mercer M.E., Holder M.D.: Antinociceptive effects of palatable sweet ingesta on human responses to pressure pain. Physiol. and Behavior, 1997, 61, 311-318.
• [39] Meydani M.: Nutrition, immune cells, and arthrosclerosis. Nutr. Rev., 1998, 56, S177-S182.
• [40] Mitchell P.J., Redman J.R.: Effects of caffeine, time of day and user history on study-related performance. Psychopharmacology, 1992, 109, 121-126.
• [41] Morris M.C., Beckett L.A., Scherr P.A., Hebert L.E., Bennet D.A., Field T.S., Evans D.A.: Vitamin E and vitamin C supplement use and risk of incident Alzheimer disease. Alzheimer disease and Associated Disorders, 1998, 12, 121-126.
• [42] Nehling A., Daval J.L., Debry G.: Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects. Brain Res. Rev., 1992, 17, 139-170.
• [43] Ortega R.M., Requejo A.M., Andrés P., Lopez-Sébaler A.M., Quintas M.E., Redondo M.R., Navia B., Rivas T.: Dietary intake and cognitive function in a group of elderly people. Am. J. Clin. Nutr., 1997, 66, 803-809.
• [44] Ortega R.M., Requejo A.M., Lopez-Sobaler A.M., Andres P., Navia B., Perea J.M., Robles F. Cognitive function in elderly people is influenced by vitamin E status. American Society for Nutritional Sciences., 2002.
• [45] Perkins A.J., Hendrie H.C., Callahan C.M., Gao S., Unverzagt F.W., Xu Y., Hall K.S., Hui S.L.: Association of antioxidants with memory in a multiethnic elderly sample using the third National Health and nutrition Examination Survey. Am. J. Epidemiol., 1999, 150, 37-44.
• [46] Ramzan I., Wong B.E., Corcoran G.B.: Pain sensitivity in dietary-induced obese rats. Physiol. and Behavior, 1993, 54, 433-435.
• [47] Rao R.: Cerebrovascular disease and later life depression: an age old association revisited. Inter. J. Geriat. Psych., 2000, 15, 419-433.
• [48] Richardson J.S.: Free radicals in the genesis of Alzheimer’s disease. An. New York Acad. Sci., 1993, 695, 73-76.
• [49] Richardson N.J., Rogers P.J., Elliman N.A., O’Dell R.J.: Mood and performance effects of caffeine in relation to acute and chronic caffeine deprivation. Pharmacol., Bioch. Behavior, 1995, 52, 313-320.
• [50] Riggs K.M., Spiro A., Tucker K., Rush D.: Relations of vitamin B-12, vitamin B-6, folate and homocysteine to cognitive performance in the Normative Aging Study. Am. J. Clin. Nutr., 1996, 63, 306-314.
• [51] Roane D.S., Martin R.J.: Continuous sucrose feeding decreases pain threshold and increases morphine potency. Pharmacol., Bioch. Behavior, 1990, 35, 225-229.
• [52] Rogers P. J. A Healthy body, a healthy mind: long-term impact of diet on mood and cognitive function. Proc. Nutr. Soc., 2001, 60, 135-143.
• [53] Rogers P.J., Richardson N.J., Dernoncourt C.: Caffeine use: is there a net benefit for mood and psychomotor performance? Neuropsychobiology, 1995, 31, 195-199.
• [54] Rosenberg I.R., Miller J.W.: Nutritional factors in physical and cognitive functions of elderly people. Am. J. Clin. Nutr., 1992, 55, 1237S-1243S.
• [55] Sano M., Ernesto C., Thomas R.G., Klauber M.R., Schafer K., Grundman M., Woodbury P., Growden J., Cotman C.W., Pfeiffer E., Schneider L.S., Thal L.J.: A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer’s disease. New Eng. J. Med., 1997, 336, 1216-1222.
• [56] Selhub J., Jaques P.F.,Wilson P.W.F., Rush D., Rosenberg I.H.: Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. J. Am. Med. Assoc., 1993, 270, 2693-2698.
• [57] Silverman K., Evans S.M., Strain E.C., Griffiths R.R.: Withdrawal syndrome after double blind cessation of caffeine consumption. New Eng. J. Med., 1992, 327, 1109-1114.
• [58] Smith A., Clark R., Nutt D., Haller J., Hayward S., Perry K.: Anti-oxidant vitamins and mental performance of the elderly. Hum. Psychopharmacol. Clin. Exp., 1999, 44, 459-471.
• [59] Smith A.P., Clark R.E., Nutt D.J., Haller J.G., Hayward S., Perry K.: Vitamin C, mood and cognitive functioning in the elderly. Nutr. Neurosci., 2000, 2, 249-256.
• [60] Smith A.P., Rusted J.M., Savory M., Eaton-Williams P., Hall S.R.: The effects of caffeine, impulsivity and time of day on performance, mood, and cardiovascular function. J. Psychopharmacol., 1991, 5, 120-128.
• [61] Sommer B.R., Wolkowitz O.M.: RBC folic acid levels and cognitive performance in elderly patients: A preliminary report. Biol. Psych., 1988, 24, 352-354.
• [62] Thomas T., Thomas G., McLendon C., Sutton T., Mullan M.: β-amyloid - mediated vasoactivity and vascular endothelial damage. Nature, 1996, 380, 168-171.
• [63] Traczyk W.Z., Trzebski A. (red.): Fizjologia człowieka z elementami fizjologii stosowanej i klinicznej. Wyd. Lek. PZWL, wyd. III, Warszawa 2001.
• [64] Ueland P.M., Refsum H.: Plasma homocysteine: A risk factor for vascular disease: Plasma levels in health, disease, and drug therapy. J. Labor. Clin. Med., 1989, 114, 472-501.
• [65] Witztum J.L.: The oxidation hypothesis of artherosclerosis. Lancet, 1994, 344, 793-795.
• [66] Woodside J.V., Yarnell J.W.G., McMaster D., Young I.S., Harmon D.L., McCrum E.E., Patterson C.C., Grey K.F., Whiteheat A.S., Evans A.: Effect of B-group vitamins and antioxidant vitamins on hyperhomocysteinemia: a double-blind, randomized, factorial design, controlled trial. Am. J. Clin. Nutr., 1998, 67, 858-866.
• [67] Young S.N.: The use of diet and dietary components in the study of factors controlling affect in humans: A review. J. Psych. Neurosci., 1993, 18, 235-244.
• [68] Ziemlański Ś. (red.): Normy żywienia człowieka, fizjologiczne podstawy. Wyd. Lek. PZWL, Warszawa 2001.